BusinessProLynx announces PLX039, a hydrogel-microsphere drug delivery system that supports once-monthly administration of a GLP-1 receptor agonistBy Nasdaq OMXJun 12, 2017, 1:00 PM UTC
BusinessFibrocell Receives Rare Pediatric Disease Designation from FDA for FCX-013 for Treatment of Localized SclerodermaBy Nasdaq OMXJun 12, 2017, 12:00 PM UTC
BusinessVascepa® (Icosapent Ethyl) Showed Reductions in Potentially Atherogenic Lipid Parameters in Statin-Treated Women With Type 2 Diabetes and Persistent High TriglyceridesBy Nasdaq OMXJun 12, 2017, 11:00 AM UTC
BusinessCascadian Therapeutics’ Lead Candidate, Tucatinib, Receives Orphan Drug Designation from FDA for Treatment of Breast Cancer Patients with Brain MetastasesBy Nasdaq OMXJun 8, 2017, 12:01 PM UTC
BusinessFibrocell Completes Dosing of First Cohort in Phase 1/2 Clinical Trial of FCX-007 Gene Therapy for Treatment of Recessive Dystrophic Epidermolysis BullosaBy Nasdaq OMXJun 8, 2017, 12:00 PM UTC
BusinessCrescendo Bioscience Announces Six Studies with Vectra® DA Will Be Presented at the 2017 Annual European Congress of RheumatologyBy Nasdaq OMXJun 8, 2017, 11:05 AM UTC
BusinessOrganovo Announces Fiscal Fourth-Quarter and Full-Year 2017 Results; Company Issues Full-Year Fiscal 2018 OutlookBy Nasdaq OMXJun 7, 2017, 8:05 PM UTC
